Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05027659 |
Other study ID # |
EYILMAZ-experimental study |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
January 2, 2020 |
Est. completion date |
December 20, 2020 |
Study information
Verified date |
August 2021 |
Source |
Kirikkale University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The present study was conducted with 44 patients who applied to the Endoscopy Unit of a
university hospital for sedation-free colonoscopy between January 2, 2020 and September 28,
2020, met the inclusion criteria and agreed to participate in the study. The patients were
homogeneously divided into experimental (n=22) and control (n=22) groups based on their
gender and history of colonoscopy. The patients in the experimental group watched a 360
degree virtual reailty (VR) video with atmospheric background music over images and sounds of
nature through virtual reality glasses while no application was performed for the patients in
the control group during the procedure. The "Demographic Information Form", "Trait Anxiety
Scale", "Visual Analog Scale-Pain", "Visual Analog Scale-Anxiety", "Vital Signs Monitoring
Chart" and "Satisfaction Evaluation on the Virtual Reality Glasses Application" forms were
used in the data collection phase. For the study, an ethics committee approval was obtained
in addition to written consent by the institutions and patients. Numbers, percentages, the
Chi-square test, the Wilcoxon test and the Mann-Whitney U test were used for data analysis.
Description:
Aims: This study investigated the effect of VR glasses on vital signs and anxiety in patients
undergoing colonoscopy. The research questions are as follows:
- Wearing VR glasses during colonoscopy affects at least one vital sign.
- Wearing VR glasses during colonoscopy affects anxiety. Study design and setting: This
study adopted a randomized controlled experimental design. The study population
consisted of all patients (N=82) who had a colonoscopy without sedation between January
2, 2020, and September 28, 2020, at the endoscopy unit of a training and research
hospital in Kırıkkale, Turkey. Patients were randomized into experimental and control
groups before the procedure.
Group 1 (experimental): Virtual reality glasses have a detachable screen frame compatible
with smartphones. A VR headset has earphones and sensors that track the user's head
movements, giving them the impression that they are moving around in a virtual environment
(Arane et al., 2017; Indovina et al., 2018). The investigators used a smartphone and VR
glasses to perform the intervention. They connected the phone to the VR headset via a 360o VR
video app. Experimental participants wore the VR glasses and watched a 360o VR video of
nature scenes with ambiance music during colonoscopy. They put on the VR glasses right before
the procedure and took them off right afterward.
Each control group participant (Group 2) underwent the standard procedure.
Sample size calculation: The sample consisted of 44 participants divided into experimental
(n=22) and control (n=22). A post-power analysis was conducted on Visual Analog Scale-Pain
(VAS-P) scores due to the pandemic. The results showed that the sample was large enough to
detect significant differences (effect size = 1.31; type I margin of error (α) = 0.05; test
power (1-β) = 0.98).
Randomization: Simple stratified randomization was used for homogeneity.Participants were
assigned to the groups based on their gender and colonoscopy history.For each patient
randomly assigned to a group (drawing lots), another patient with the same gender and
colonoscopy history was included in the other group. For example, the investigators wrote
down "experimental" and "control" on pieces of paper for a female participant scheduled for a
colonoscopy for the first time and put them in a bag. Then, they asked the nurse in charge to
pull one of the pieces of paper out of the bag. In this way, that participant was assigned to
the group written on the piece of paper. Afterward, the investigators assigned another
patient with the same gender and colonoscopy history to the other group. The nurse pulled a
new piece of paper out of the bag for a patient with a different gender and colonoscopy
history. The investigatorsassigned that patient to the corresponding group. They followed the
same procedure for all groups (Woman-first time colonoscopy; Woman- colonoscopy before;
Man-first time colonoscopy; Man- colonoscopy before) to achieve homogenous groups.
Research shows that gender and colonoscopy history affect pain and anxiety during
colonoscopy. Therefore, the investigators used the same parameters to randomize participants
into the groups, which were similar in terms of gender and colonoscopy history.
Data collection tools: Data were collected using a demographic characteristics questionnaire
and the Visual Analog Scale-Anxiety (VAS-A). Vital signs (Blood pressure, pulse rate, and
SpO2) were also measured using a monitor. The respiratory rate was measured by the
researcher. The pain was assessed using the Visual Analog Scale-Pain (VAS-P). A five-point
scale ("very satisfied,""satisfied,""undecided,""dissatisfied," and "very dissatisfied") was
used to determine how satisfied participants were with wearing the VR glasses during the
procedure.
Research Implementation: Patients were informed about the research purpose and procedure, and
consent was obtained from those who agreed to participate. All participants filled out the
demographic characteristics questionnaire, VAS-P, and VAS-A, and their vital signs were
measured before colonoscopy. The experimental group participants wore the VR glasses and
watched a 360 degree VR video of nature scenes with ambiance music during colonoscopy. The
control group participants underwent the standard procedure. All participants filled out the
VAS-P and VAS-A, and their vital signs were measured after the procedure. How satisfied the
experimental group participants were with the VR application was also assessed after the
procedure.
Ethical Consideration: The study was approved by an ethics committee (Date: 31.07.2019 &
No:44). Permission was obtained from the hospital (Date: 07.08.2019 & No: 28955). Patients
were informed about the research purpose, procedure, and confidentiality prior to
participation and that they could withdraw from the study at any time without any monetary
concessions. Written consent was obtained from those who agreed to participate. Permission
was obtained from the developer of the 360 degree VR video.